What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients? Comment

被引：1
作者：
Silvestris, Nicola [1 ,2 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II Bari, Med Oncol Unit, I-70124 Bari, Italy
[2] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, I-70124 Bari, Italy
来源：
EBIOMEDICINE | 2021年 / 74卷
关键词：
D O I：
10.1016/j.ebiom.2021.103733
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Noa Dagan
    Noam Barda
    Tal Biron-Shental
    Maya Makov-Assif
    Calanit Key
    Isaac S. Kohane
    Miguel A. Hernán
    Marc Lipsitch
    Sonia Hernandez-Diaz
    Ben Y. Reis
    Ran D. Balicer
    Nature Medicine, 2021, 27 : 1693 - 1695
  • [42] Humoral and Innate Immunological Profile of Paediatric Recipients of Pfizer-BioNTech BNT162b2 mRNA Vaccine
    Jeremiah, Sundararaj Stanleyraj
    Das, Priya
    Venkatesan, Manu
    Albinzayed, Reem
    Ahmed, Aysha
    Stevenson, Nigel John
    Corbally, Martin
    Alqahtani, Manaf
    Al-Wedaie, Fatima
    Farid, Eman
    Hejres, Suha
    MICROORGANISMS, 2024, 12 (07)
  • [43] Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
    Ligumsky, Hagai
    Dor, Herut
    Etan, Tal
    Golomb, Inbal
    Nikolaevski-Berlin, Alla
    Greenberg, Inbal
    Halperin, Tamar
    Angel, Yoel
    Henig, Oryan
    Spitzer, Avishay
    Slobodkin, Marina
    Wolf, Ido
    LANCET ONCOLOGY, 2022, 23 (02) : 193 - 195
  • [44] The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses
    Foehse, Konstantin
    Geckin, Buesra
    Zoodsma, Martijn
    Kilic, Gizem
    Liu, Zhaoli
    Roering, Rutger J.
    Overheul, Gijs J.
    van de Maata, Josephine
    Buluta, Ozlem
    Hoogerwerf, Jacobien J.
    ten Oever, Jaap
    Simonetti, Elles
    Schaal, Heiner
    Adams, Ortwin
    Mueller, Lisa
    Ostermann, Philipp Niklas
    van de Veerdonk, Frank L.
    Joosten, Leo A. B.
    Haagmans, Bart L.
    van Crevel, Reinout
    van Rij, Ronald P.
    Geurtsvankessel, Corine
    de Jonge, Marien I.
    Li, Yang
    Dominguez-Andres, Jorge
    Netea, Mihai G.
    CLINICAL IMMUNOLOGY, 2023, 255
  • [45] Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
    Graydon, Elizabeth K.
    Conner, Tonia L.
    Dunham, Kim
    Olsen, Cara
    Goguet, Emilie
    Coggins, Si'Ana A.
    Rekedal, Marana
    Samuels, Emily
    Jackson-Thompson, Belinda
    Moser, Matthew
    Lindrose, Alyssa
    Hollis-Perry, Monique
    Wang, Gregory
    Maiolatesi, Santina
    Alcorta, Yolanda
    Reyes, Anatalio
    Wong, Mimi
    Ramsey, Kathy
    Davies, Julian
    Parmelee, Edward
    Ortega, Orlando
    Sanchez, Mimi
    Moller, Sydney
    Inglefield, Jon
    Tribble, David
    Burgess, Timothy
    O'Connell, Robert
    Malloy, Allison M. W.
    Pollett, Simon
    Broder, Christopher C.
    Laing, Eric D.
    Anderson, Stephen K.
    Mitre, Edward
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] BNT162b2 mRNA COVID-19 Vaccine: First Approval
    Lamb, Yvette N.
    DRUGS, 2021, 81 (04) : 495 - 501
  • [47] Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine
    Lopez-Valle, Alba
    Falkenhain-Lopez, Daniel
    Arranz, Celia R.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (07) : 891 - 892
  • [48] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
    Payne, Rebecca P.
    Longet, Stephanie
    Austin, James A.
    Skelly, Donal T.
    Dejnirattisai, Wanwisa
    Adele, Sandra
    Meardon, Naomi
    Faustini, Sian
    Al-Taei, Saly
    Moore, Shona C.
    Tipton, Tom
    Hering, Luisa M.
    Angyal, Adrienn
    Brown, Rebecca
    Nicols, Alexander R.
    Gillson, Natalie
    Dobson, Susan L.
    Amini, Ali
    Supasa, Piyada
    Cross, Andrew
    Bridges-Webb, Alice
    Reyes, Laura Silva
    Linder, Aline
    Sandhar, Gurjinder
    Kilby, Jonathan A.
    Tyerman, Jessica K.
    Altmann, Thomas
    Hornsby, Hailey
    Whitham, Rachel
    Phillips, Eloise
    Malone, Tom
    Hargreaves, Alexander
    Shields, Adrian
    Saei, Ayoub
    Foulkes, Sarah
    Stafford, Lizzie
    Johnson, Sile
    Wootton, Daniel G.
    Conlon, Christopher P.
    Jeffery, Katie
    Matthews, Philippa C.
    Frater, John
    Deeks, Alexandra S.
    Pollard, Andrew J.
    Brown, Anthony
    Rowland-Jones, Sarah L.
    Mongkolsapaya, Juthathip
    Barnes, Eleanor
    Hopkins, Susan
    Hall, Victoria
    CELL, 2021, 184 (23) : 5699 - +
  • [49] Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma
    Avivi, Irit
    Balaban, Roi
    Shragai, Tamir
    Sheffer, Gabi
    Morales, Miguel
    Aharon, Anat
    Lowenton-Spier, Noa
    Trestman, Svetlana
    Perry, Chava
    Benyamini, Noam
    Mittelman, Moshe
    Tabib, Yaara
    Bar Lev, Tali
    Zavaro, Mor
    Herishanu, Yair
    Luttwak, Efrat
    Cohen, Yael C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (02) : 186 - 193
  • [50] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Polack, Fernando P.
    Thomas, Stephen J.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Perez, John L.
    Perez Marc, Gonzalo
    Moreira, Edson D.
    Zerbini, Cristiano
    Bailey, Ruth
    Swanson, Kena A.
    Roychoudhury, Satrajit
    Koury, Kenneth
    Li, Ping
    Kalina, Warren V.
    Cooper, David
    Frenck, Robert W., Jr.
    Hammitt, Laura L.
    Tureci, Ozlem
    Nell, Haylene
    Schaefer, Axel
    Unal, Serhat
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) : 2603 - 2615
12345